These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 24201391)

  • 1. Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin.
    Thomassen I; van Gestel YR; Lemmens VE; de Hingh IH
    Dis Colon Rectum; 2013 Dec; 56(12):1373-80. PubMed ID: 24201391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively.
    Allard MA; Adam R; Ruiz A; Vibert E; Paule B; Levi F; Sebagh M; Guettier C; Azoulay D; Castaing D
    Eur J Surg Oncol; 2013 Sep; 39(9):981-7. PubMed ID: 23845705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent? A case-control study.
    Maggiori L; Goéré D; Viana B; Tzanis D; Dumont F; Honoré C; Eveno C; Elias D
    Ann Surg; 2013 Jul; 258(1):116-21. PubMed ID: 23207243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection.
    Chua TC; Yan TD; Zhao J; Morris DL
    Eur J Surg Oncol; 2009 Dec; 35(12):1299-305. PubMed ID: 19632081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.
    van Gestel YR; Thomassen I; Lemmens VE; Pruijt JF; van Herk-Sukel MP; Rutten HJ; Creemers GJ; de Hingh IH
    Eur J Surg Oncol; 2014 Aug; 40(8):963-9. PubMed ID: 24183168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.
    da Silva RG; Sugarbaker PH
    J Am Coll Surg; 2006 Dec; 203(6):878-86. PubMed ID: 17116556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study.
    Quere P; Facy O; Manfredi S; Jooste V; Faivre J; Lepage C; Bouvier AM
    Dis Colon Rectum; 2015 Aug; 58(8):743-52. PubMed ID: 26163953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of surgery for colorectal cancer in the presence of peritoneal carcinomatosis.
    Klaver YL; Lemmens VE; de Hingh IH
    Eur J Surg Oncol; 2013 Jul; 39(7):734-41. PubMed ID: 23523316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study.
    Lemmens VE; Klaver YL; Verwaal VJ; Rutten HJ; Coebergh JW; de Hingh IH
    Int J Cancer; 2011 Jun; 128(11):2717-25. PubMed ID: 20715167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of biological therapies to palliative chemotherapy prolongs survival in patients with peritoneal carcinomatosis of colorectal origin.
    Klaver YL; Leenders BJ; Creemers GJ; Rutten HJ; Verwaal VJ; Lemmens VE; de Hingh IH
    Am J Clin Oncol; 2013 Apr; 36(2):157-61. PubMed ID: 22314003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian metastasis is associated with retroperitoneal lymph node relapses in women treated for colorectal peritoneal carcinomatosis.
    Eveno C; Goéré D; Dartigues P; Honoré C; Dumont F; Tzanis D; Benhaim L; Malka D; Elias D
    Ann Surg Oncol; 2013 Feb; 20(2):491-6. PubMed ID: 22956066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer.
    Elias D; Benizri E; Pocard M; Ducreux M; Boige V; Lasser P
    Eur J Surg Oncol; 2006 Aug; 32(6):632-6. PubMed ID: 16621428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes following surgery for colorectal cancer with synchronous peritoneal metastases.
    Mulsow J; Merkel S; Agaimy A; Hohenberger W
    Br J Surg; 2011 Dec; 98(12):1785-91. PubMed ID: 22034185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.
    Koppe MJ; Boerman OC; Oyen WJ; Bleichrodt RP
    Ann Surg; 2006 Feb; 243(2):212-22. PubMed ID: 16432354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal carcinomatosis from colorectal cancer.
    Jayne DG; Fook S; Loi C; Seow-Choen F
    Br J Surg; 2002 Dec; 89(12):1545-50. PubMed ID: 12445064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer.
    Carmignani CP; Ortega-Perez G; Sugarbaker PH
    Eur J Surg Oncol; 2004 May; 30(4):391-8. PubMed ID: 15063892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multidisciplinary approach for peritoneal carcinomatosis and bilobar liver metastases from colorectal cancer: case report and review of the literature.
    Ramírez-Plaza CP; Moreno-Ruiz FJ; Pérez-Daga JA
    World J Surg Oncol; 2015 Aug; 13():233. PubMed ID: 26231227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of colorectal liver metastases in patients with peritoneal carcinomatosis.
    Izzo F; Piccirillo M; Palaia R; Albino V; Di Giacomo R; Mastro AA
    J Surg Oncol; 2009 Sep; 100(4):345-7. PubMed ID: 19697443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study.
    Thomassen I; Lemmens VE; Nienhuijs SW; Luyer MD; Klaver YL; de Hingh IH
    Pancreas; 2013 Jan; 42(1):72-5. PubMed ID: 22850624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of cytoreductive surgery alone for the treatment of peritoneal carcinomatosis of colorectal origin. A retrospective analysis with regard to multimodal treatments.
    Scaringi S; Leo F; Canonico G; Batignani G; Ficari F; Tonelli F
    Hepatogastroenterology; 2009; 56(91-92):650-5. PubMed ID: 19621673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.